Jyoti CNC Q1FY27: consolidated PAT falls 20% YoY as French subsidiary losses hit margins

Jyoti CNC's Q1FY27 (quarter ended June 30, 2026) consolidated print was mixed: revenue rose 23.97% YoY to ₹508.47 Cr (₹410.17 Cr a year ago) but PAT fell 19.99% YoY to ₹57.14 Cr (₹71.42 Cr) — profit declining even as the top line grew. Sequentially both metrics eased from a stronger Q4FY26 (revenue -15.13% QoQ from ₹599.16 Cr, PAT -36.92% QoQ from ₹90.57 Cr), consistent with a seasonally softer Q1 for an order-book-driven capital-goods business. Consolidated EPS was ₹2.51 versus ₹3.14 a year ago. No reliable street estimates specific to this quarter's print could be sourced, so the actual cannot be benchmarked against consensus (vsStreet: unknown).

The YoY profit decline sits entirely on the margin line, not on any exceptional item — both periods show nil exceptional/extraordinary items. Consolidated NPM compressed to 11.24% from 16.58% a year ago, and OPM (EBITDA margin) fell to 21.40% from 24.43%, both now below management's own guided 25-27% EBITDA margin band for FY27/FY28 laid out on the Q3FY26 concall. The compression traces to the group's overseas operations: per the auditor's review note, subsidiaries and step-down subsidiaries (including the French Huron entities) posted a combined net loss of ₹30.07 Cr on just ₹32.21 Cr of revenue this quarter. That overseas drag is the entire story behind the standalone-vs-consolidated gap — standalone (parent-only) PAT was ₹87.47 Cr, up 21.28% YoY, with EPS of ₹3.85, more than 50% higher than the consolidated EPS.

The stock went into the print at ₹797.15, up 3.7% over the past month of trading.

The overseas drag is not new: step-down subsidiary Huron Graffenstaden SAS (France) remains under an ongoing French judicial investigation into alleged dual-use export-control violations, with interim seizure of €3.02 million in funds and two Jyoti SAS-owned residential properties, and restrictions on the entity's Director General — unchanged from prior disclosures. Standalone financials also carry a management note that no impairment has been taken on the investment in this loss-making subsidiary chain, on the view that recovery is likely and the investment remains strategic — auditors did not qualify this but it is a judgment call worth tracking. On revenue, consolidated growth of 23.97% YoY trails the lower end of management's guided 25-30% FY27 band (given alongside confidence in tripling India capacity by September 2026); the quarter is a narrow miss on revenue guidance and a more pronounced miss on the margin guidance.